COMMUNIQUÉS West-GlobeNewswire

Physicians Subjected to Unreliable ‘Lie-Detector’ Tests, according to the Journal of American Physicians and Surgeons
02/06/2026
TUCSON, Ariz., June 02, 2026 (GLOBE NEWSWIRE) -- Although polygraphs (“lie-detector” tests) are considered too unreliable to be admissible in federal and most state courts, physicians are often being forced to submit to [...]
Adverse Effects of COVID Vaccine on Musculoskeletal Conditions Need Research, according to the Journal of American Physicians and Surgeons
02/06/2026
TUCSON, Ariz., June 02, 2026 (GLOBE NEWSWIRE) -- The contentious issue of musculoskeletal adverse effects of COVID-19 vaccines arises in the context of the collapse of public trust in academic expertise, writes Jane M. [...]
Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
02/06/2026
$8.5 million upfront with up to approximately $15.1 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond [...]
GENFIT Annual General Meeting of June 15, 2026 - Shareholders' letter
02/06/2026
Dear Shareholders, We are pleased to send you, in the attached document, GENFIT’s Shareholders’ Letter published ahead of our Annual General Meeting to be held on June 15, 2026. This letter outlines the key elements [...]
GENFIT : Assemblée Générale Mixte du 15 juin 2026 - Lettre aux actionnaires
02/06/2026
Chers Actionnaires, Nous avons le plaisir de vous adresser, en pièce jointe, la Lettre aux actionnaires de GENFIT publiée à l’approche de notre Assemblée Générale Mixte du 15 juin 2026. Cette lettre revient sur les [...]
AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share
02/06/2026
PRESS RELEASE STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE’S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE Paris, June 2 nd , 2026, 6pm CET AB Science SA (Euronext - [...]
AB Science : Stonegate Capital Partners actualise sa couverture de l'action AB Science avec un objectif de cours de 4,25 EUR par action
02/06/2026
COMMUNIQUÉ DE PRESSE STONEGATE CAPITAL PARTNERS ACTUALISE SA COUVERTURE DE L'ACTION AB SCIENCE AVEC UN OBJECTIF DE COURS DE 4,25 EUR PAR ACTION EN VALEUR MÉDIANE, SUR LA BASE DES FLUX DE TRÉSORERIE ACTUALISÉS Paris, 2 [...]
CROSSJECT met à disposition les réponses aux questions de ses actionnaires préalablement à son Assemblée Générale
02/06/2026
CROSSJECT met à disposition les réponses aux questions de ses actionnaires préalablement à son Assemblée Générale Dijon, France 02 juin 2026 (17h45 CET) -- CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ) , la société [...]
Update on the Carbios - Wankai project in China
02/06/2026
Clermont-Ferrand (France), 2 June 2026 (05:45 pm CEST). Carbios (Euronext Growth Paris: ALCRB) provides an update on the progress of its strategic partnership with Wankai New Materials (“ Wankai ”) in the field of PET [...]
Point d’avancement sur le projet Carbios - Wankai en Chine
02/06/2026
Clermont-Ferrand (France), 2 juin 2026 (17h45 CEST). Carbios (Euronext Growth Paris : ALCRB) fait le point sur l’avancement de son partenariat stratégique avec Wankai New Materials (« Wankai ») dans le domaine du [...]
NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome™ Commercialization
02/06/2026
Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to $MAJI shareholders. ORLANDO, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- [...]
FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
02/06/2026
Guidance shows how sponsors can build on existing science, reducing redundant testing and accelerating treatments for patients with rare and life-threatening diseases Silver Spring, MD, June 02, 2026 (GLOBE NEWSWIRE [...]
Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
02/06/2026
Press release – No. 12 / 2026 Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference Copenhagen, Denmark, June 2, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology [...]
OncoBag launches innovative handbag for post-mastectomy women
02/06/2026
Polish Femtech pioneer begins pre-sales of revolutionary OncoBag Wroclaw, Poland, June 02, 2026 (GLOBE NEWSWIRE) -- OncoBag, a pioneering Polish femtech and wellness company, has announced the pre-sale of its [...]
New Study: Baby Gut Microbiome Differences Linked to Eczema and Food Allergy Emerge by 6 Months
02/06/2026
Research from Tiny Health and Free to Feed, published in Frontiers in Microbiomes, finds the gut microbiomes of infants with eczema or food allergies begin to look different from healthy peers as early as 6 months old [...]
Jersey College Offers Associate Degree for NJ Nursing Students With and Without Prior Licensure
02/06/2026
Teterboro and Ewing campuses offer full ADN program. Next class starts August 17. TETERBORO, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- Jersey College , the institution dedicated to excellence in nursing education, [...]
Oraticx Expands Oral Probiotics Lineup for Daily Oral Care and Oral Microbiome Wellness
02/06/2026
New product range introduces targeted probiotic oral care solutions for everyday wellness routines Oraticx Logo LOS ANGELES, June 02, 2026 (GLOBE NEWSWIRE) -- Oraticx, a wellness brand focused on oral microbiome balance [...]
MAPS Publishes First-of-Its-Kind Literature Review on Psychedelic Healing for People Impacted by the Criminal Legal System
02/06/2026
“Relocating the Root” is a scoping literature review on the mental health needs of people directly impacted by the criminal legal system Publishing this literature review launches a project that builds on nearly four [...]
MAIA Biotechnology Announces Open Market Purchases by CEO and Director
02/06/2026
CHICAGO, June 02, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, [...]

Pages